Results 1 to 10 of about 21,522 (206)

Influence of allelic variations in relation to norepinephrine and mineralocorticoid receptors on psychopathic traits: a pilot study [PDF]

open access: goldPeerJ, 2018
Background Past findings support a relationship between abnormalities in the amygdala and the presence of psychopathic traits. Among other genes and biomarkers relevant to the amygdala, norepinephrine and mineralocorticoid receptors might both play a ...
Guillaume Durand
doaj   +4 more sources

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2023
Pulmonary hypertension (PH) is characterized by pulmonary vascular remodeling and associated with adverse outcomes. In patients with PH, plasma aldosterone levels are elevated, suggesting that aldosterone and its receptor, the mineralocorticoid receptor (
Argen Mamazhakypov   +2 more
doaj   +2 more sources

Cardiac response to chronic restraint stress involves mineralocorticoid receptors in male Sprague–Dawley rats [PDF]

open access: yesPhysiological Reports
In the present study, we aimed at elucidating whether exposure to chronic stress affects the expression of cardiac mineralocorticoid receptors (MRs), whether it influences cardiac structure and function, and whether MRs blockade attenuates the stress ...
D. Sztechman   +4 more
doaj   +2 more sources

Vascular cell‐specific roles of mineralocorticoid receptors in pulmonary hypertension [PDF]

open access: yesPulmonary Circulation, 2021
Abnormalities that characterize pulmonary arterial hypertension include impairment in the structure and function of pulmonary vascular endothelial and smooth muscle cells.
Divya P. Menon   +10 more
doaj   +2 more sources

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis. [PDF]

open access: yesFrontiers in Endocrinology, 2015
Atherosclerosis is a chronic inflammatory disease of the vasculature that causes significant morbidity and mortality from myocardial infarction, stroke, peripheral vascular disease, and heart failure.
Mary Elizabeth Moss   +3 more
doaj   +2 more sources

FRI162 Ligand-dependent Photocrosslinking of Mineralocorticoid Receptors Using Site-directed Incorporation of Unnatural Amino Acids [PDF]

open access: goldJ Endocr Soc, 2023
Brian Almeida‐Prieto   +3 more
europepmc   +2 more sources

Glucocorticoid and mineralocorticoid receptors and corticosteroid homeostasis are potential targets for endocrine-disrupting chemicals

open access: yesEnvironment International, 2019
Endocrine-disrupting chemicals (EDCs) have received significant concern, since they ubiquitously exist in the environment and are able to induce adverse health effects on human and wildlife. Increasing evidence shows that the glucocorticoid receptor (GR)
Jianyun Zhang, Ye Yang, Weiping Liu
exaly   +3 more sources

Mineralocorticoid Receptor Antagonists [PDF]

open access: yesInternational Cardiovascular Forum Journal, 2019
Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in clinical trials for indications including heart failure, hypertension and diabetic kidney disease, and even more structurally distinct chemical series are reported in the literature with preclinical data
Anneli, Nordqvist, Kenneth L, Granberg
  +5 more sources

The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice

open access: yesPharmaceutics, 2023
Tacrolimus (Tac) is a calcineurin inhibitor commonly used as an immunosuppressor after solid organ transplantation. However, Tac may induce hypertension, nephrotoxicity, and an increase in aldosterone levels.
Stefanny M. Figueroa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy